Cogo (COGO) Announces Continued Progress on Proposed Asset Purchase

Linn Energy (LINE) and Triangle Petroleum Shares Jump as Oil Prices Rebound

NEW YORK, NY — (Marketwire) — 06/29/12 — Oil stocks received a boost earlier this week as oil prices rose on positive U.S. manufacturing and housing data. Oil futures on Wednesday rallied back above $80 a barrel, the highest level in the past week. The SPDR S&P Oil & Gas Exploration & Production ETF (XOP) surged 4 percent on Wednesday. The Paragon Report examines investing opportunities in the Oil & Gas Industry and provides equity research on Linn Energy, LLC (NASDAQ: LINE) and Triangle Petroleum Corporation (NYSE: TPLM).

Access to the full company reports can be found at:

www.ParagonReport.com/LINE

www.ParagonReport.com/TPLM

Data from the Commerce Department showed that factories received more orders for durable goods in May than previously forecasted. The National Association of Realtors also reported that pending U.S. home sales in May were at their highest levels in over two years. “The durable goods number is giving the market the sense that things aren’t too bad, at least in the U.S.,” said Phil Flynn, senior market analyst at the Price Futures Group. “The economic data recently seems to be raising expectations for more oil demand.”

On another note, the Energy Department’s Energy Information Administration in their weekly report stated U.S. crude oil supplies fell by 100,000 barrels for the week ended June 22. According to Platts analysts had expected a decrease of 1 million barrels.

Paragon Report releases regular market updates on the Oil & Gas Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.ParagonReport.com and get exclusive access to our numerous stock reports and industry newsletters.

LINN Energy recently announced the acquisition of BP’s Jonah Field properties, located in the Green River Basin of southwest Wyoming, for $1.025 billion. Including the pending Jonah Field transaction, LINN has announced or closed almost $3 billion of acquisitions year to date. Shares of the company rose 3 percent Wednesday.

Triangle Petroleum is a growth-oriented oil and gas exploration and development company with approximately 82,000 net acres in the Williston Basin targeting the Bakken Shale and Three Forks formations. The company reported first quarter fiscal 2013 total production of 62,700 Boe. As of April 30, 2012 Triangle Petroleum had a cash balance of $34 million.

Paragon Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Paragon Report has not been compensated by any of the above-mentioned companies. We act as independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at:
www.ParagonReport.com/disclaimer

Dynasil (DYSL) Appoints Chairman Peter Sulick as Interim Chief Executive Officer and President

Dynasil Corporation of America (NASDAQ: DYSL) today announced that Steven K. Ruggieri will resign as Chief Executive Officer and President and as a member of the Board of Directors effective July 6, 2012. Dynasil Chairman Peter Sulick will serve as the Company’s Interim Chief Executive Officer and President until a replacement is named by the Board.

“During his tenure with the Company, Steve helped to further the commercialization strategy for our dual mode technology, advanced our product pipeline and strengthened our business development initiatives,” Sulick said. “On behalf of the Board, I want to wish Steve success as he pursues new endeavors and thank him for his contributions to Dynasil.”

“The Board will begin the search process, which is centered on identifying the right senior executive to maximize the value of our products and technology and enhance shareholder value,” Sulick said. “Our strategy continues to focus on leveraging our research organization and accelerating the commercialization of new products.”

Sulick, 61, has been a director of the Company since 2008 and has served as the non-executive Chairman of the Board since September 2009. He chaired the Audit Committee from July 2008 to February 2012, and has served on the Nominating and Governance Committee since 2010. In addition to his new role, Sulick will remain Chairman of the Board.

Sulick is President and CEO of AmeriSite, LLC, a family-owned real estate development and Investment Company he founded in 1998 and is the Executive Chairman and former CEO of Prism Microwave, Inc., which provides RF conditioning products for the mobile wireless infrastructure industry. From 1985 to 2002, Sulick founded and led broadcasting and telecommunications companies that were later acquired by Nextel, T-Mobile and others. Earlier in his career he worked for Cablevision Systems Corporation and the Communications Operations Group of ITT. He began his career in the audit department at Arthur Andersen & Co. in New York City. A certified public accountant, Sulick received his MBA in finance from the University of Massachusetts and a B.S. in Business Administration from The Citadel.

About Dynasil

Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management. These forward-looking statements may be identified by the use of words such as “may,” “could,” “expect,” “estimate,” “anticipate,” “continue” or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, our ability to develop and commercialize our products, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management personnel, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company’s Annual Report on Form 10-K and from time to time in the Company’s other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

PowerSecure (POWR) Supports Utilities and Customers During Tropical Storm Debby

IDG Systems Protect Florida Facilities and Utility Crews Help Restore Power

PowerSecure International, Inc. (Nasdaq: POWR) today reported that it supported Florida utilities and customers during Tropical Storm Debby. PowerSecure’s Interactive Distributed Generation^® (IDG^®) power systems were in operation during the storm to deliver emergency power protecting over forty Florida customer facilities. The Company’s IDG monitoring team stood watch throughout the storm, ensuring backup power was available when needed, and protecting customer facilities from costly business interruptions and spoilage. PowerSecure also reported that it deployed Utility Services crews to assist with power restoration efforts. PowerSecure dispatched over fifty personnel to support utilities’ efforts to restore power as quickly as possible.

Sidney Hinton, CEO of PowerSecure, said, “Our IDG and Utility Services teams were in storm mode supporting utilities and their commercial and industrial customers before, during, and after Tropical Storm Debby. Our teams are experienced and tested in situations like these, and I am pleased to report that they executed flawlessly. We will closely monitor tropical conditions all season long and our teams will be well prepared to act on behalf of our customers and utility partners during storm events.”

About PowerSecure

PowerSecure International, Inc. is a leading provider of Utility and Energy Technologies to electric utilities, and their industrial, institutional, and commercial customers. PowerSecure provides products and services in the areas of Energy Efficiency, Interactive Distributed Generation, and Utility Infrastructure. The Company is a pioneer in developing Interactive Distributed Generation^® power systems with sophisticated smart grid capabilities, including the ability to 1) forecast electricity demand and electronically deploy the systems to deliver more efficient, and environmentally friendly power at peak power times, 2) provide utilities with dedicated electric power generation capacity to utilize for demand response purposes, and 3) provide customers with the most dependable standby power in the industry. The Company’s Energy Efficiency business develops energy efficient lighting technologies that improve the quality of light, including its proprietary EfficientLights^® LED lighting products for grocery, drug, and convenience stores, and its SecureLite and PowerLite street lights for utilities and municipalities. PowerSecure also provides electric utilities with transmission and distribution infrastructure maintenance and construction services, and engineering and regulatory consulting services. Additional information is available at www.powersecure.com.

All forward-looking statements contained in this release are made within the meaning of and pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are all statements other than statements of historical facts, including but not limited to statements concerning the amount and timing of the revenues associated with the new business discussed in this press release; the Company’s outlook, prospects and expectations for revenues, net income, and E.P.S. results and growth generally; the anticipated results of the Company’s products, services, and technologies; and all other statements concerning the plans, intentions, expectations, projections, hopes, beliefs, objectives, goals and strategies of management, including statements about other future financial and non-financial items, performance or events and about present and future products, services, technologies and businesses; and statements of assumptions underlying the foregoing. Forward-looking statements are not guarantees of future performance or events and are subject to a number of known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed, projected or implied by such forward-looking statements. Important risks, uncertainties and other factors include, but are not limited to, those risks, uncertainties and other factors identified from time to time in the Company’s most recent Annual Report on Form 10-K, as well as in subsequent filings with the Securities and Exchange Commission, including reports on Forms 10-Q and 8-K. Accordingly, there can be no assurance that the results expressed, projected or implied by any forward-looking statements will be achieved, and readers are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements in this press release speak only as of the date hereof and are based on the current plans, goals, objectives, strategies, intentions, expectations and assumptions of, and the information currently available to, management. The Company assumes no duty or obligation to update or revise any forward-looking statements for any reason, whether as the result of changes in expectations, new information, future events, conditions or circumstances or otherwise.

CAMAC Energy (CAK) Announces Completion of OML 120/121 Acquisition

CAMAC Energy Inc. (NYSE Amex: CAK), today announced that Allied Energy PLC (“Allied”), an affiliate of the Company’s largest shareholder, has closed the previously announced transaction to acquire the 40% working interest in Nigerian OMLs 120 and 121 (the “OMLs”) from Nigerian Agip Exploration (“NAE”), a subsidiary of Eni SpA (“Eni”).

Allied has informed the Company that it plans to continue the development of the Oyo Field by drilling a new well in the fourth quarter of 2012. The new well, Oyo #7, is being designed not only to increase production from the 75 million barrels of reserves (1P, 2P and 3P) in the Pliocene reservoir, but also to test the prospective resource potential of the deeper Miocene reservoir in the field. With these dual objectives, the #7 well is expected to both significantly increase oil production from the currently producing reservoir and de-risk much of the unrisked resource potential in the rest of OMLs, independently estimated at over 2 billion barrels of oil.

Allied intends to engage CAMAC Energy to act as its technical service advisor, and the Company is currently engaged in advanced negotiations with drilling rig contractors and other critical service providers on behalf of Allied. The Company will continue to provide updates on these negotiations and other critical milestones as the well #7 spud date approaches.

“We are very pleased that Allied has officially closed its purchase of NAE’s interest in OML120 and 121, and we would like to thank NAE and Allied for their steadfast commitment and diligence in executing the transaction,” said Chairman and Chief Executive Officer, Dr. Kase Lawal. “Today is an important day for CAMAC Energy and its shareholders, as we finally remove the operational uncertainty on OML 120 and 121. With the completion of this transaction, the Company can focus on increasing the value of its Nigerian assets, as well as its frontier exploration acreage. We look forward to working with our partner Allied to execute our drilling program and to significantly increase oil production.”

About CAMAC Energy Inc.

CAMAC Energy Inc. (NYSE Amex: CAK) is a U.S.-based energy company engaged in the exploration, development and production of oil and gas. The Company currently has operations in Nigeria and, through its Pacific Asia Petroleum subsidiaries, in China. The Company’s principal assets include interests in OML 120 and OML 121, offshore oil and gas leases in deep water Nigeria which include the currently producing Oyo Oilfield, and a 100% interest in the Zijinshan Block gas asset located in the Shanxi Province, China. CAMAC Energy is currently pursuing additions to its exploration portfolio in East and West Africa and has recently acquired exploration acreage in Kenya and Gambia. The Company was founded in 2005 and has offices in Houston, Texas, Beijing, China, and Lagos, Nigeria.

Forward-Looking Statements

This press release may contain certain “forward-looking statements” relating to the business of CAMAC Energy Inc. and its subsidiaries. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the general ability of CAMAC Energy Inc. to achieve its commercial objectives; the business strategy, plans and objectives of CAMAC Energy Inc. and its subsidiaries; the timing and potential results of planned drilling operations; and any other statements of non-historical information. Words such as “anticipates,” “expects,” “plans,” “projects,” “believes,” “seeks,” “estimates,” and similar expressions are intended to identify such forward-looking statements. The statements are based upon management’s current expectations, estimates and projections, are not guarantees of future performance, and are subject to a variety of risks, uncertainties and other factors, some of which are beyond CAMAC Energy Inc.’s control and are difficult to predict, including those discussed in CAMAC Energy Inc.’s periodic reports that are filed with the SEC and available on its website (http://www.sec.gov). You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Unless legally required, CAMAC Energy Inc. undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Hampton Roads (HMPR) Closes on $50 Million Private Placement of Common Stock

NORFOLK, Va., June 27, 2012 (GLOBE NEWSWIRE) — Hampton Roads Bankshares, Inc. (Nasdaq:HMPR) (the “Company”), the holding company for The Bank of Hampton Roads (“BHR”) and Shore Bank, today announced that it has closed a $50 million private placement of common stock (the “Private Placement”). The Company issued an aggregate 71,428,572 common shares at a price of $0.70 per share to the following entities or their affiliates or managed funds: Anchorage Capital Group, L.L.C., CapGen Capital Group VI LP and The Carlyle Group (together, the “Investors”) pursuant to the terms of a standby purchase agreement between the Investors and the Company.

The Company plans to raise an additional approximately $30 million to $45 million in capital by issuing from 42,836,460 to 64,285,714 common shares in a public rights offering (the “Rights Offering”) that it expects to undertake during the third quarter of 2012. In the Rights Offering, the Company will grant each of its shareholders other than the Investors non-transferable rights to purchase up to, but no more than, a pro rata share of the maximum $95 million in capital to be raised in the Private Placement and the Rights Offering. The rights will be distributed to shareholders of record as of May 31, 2012 and may be exercised at $0.70 per share, the same price per share paid by the Investors in the Private Placement. The Rights Offering will commence upon the registration statement for the Rights Offering shares being declared effective by the Securities and Exchange Commission (the “SEC”).

The Investors have agreed not to participate in the Rights Offering and have agreed to serve as standby purchasers of all or a portion of the shares offered but not purchased in the Rights Offering (the “Standby Purchase”). The number of shares the Investors purchase as standby purchasers and the ultimate size of the combined capital raise will depend on the level of shareholder participation in the Rights Offering.

In addition, the Investors have terminated warrants they hold to purchase 1,836,302 shares of the Company’s common stock at a current exercise price, subject to adjustment, of $10.00 per share.

The Company expects to use the proceeds from the Private Placement and Rights Offering for general corporate purposes, which will include, but not be limited to, making capital contributions to its banking subsidiaries.

Additional Information

Purchases of Common Stock by the Investors in the Private Placement and Standby Purchase discussed in this press release involve the sale of securities in private transactions, and such shares have not been registered under the Securities Act of 1933.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Caution About Forward-Looking Statements

Certain statements made in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are statements that include projections, predictions, expectations, or beliefs about events or results or otherwise are not statements of historical facts, such as statements regarding the purpose, timing, consummation and consequences of the transactions described herein, including the Rights Offering and Standby Purchase. Although the Company believes that its expectations with respect to such forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that actual results, performance or achievements of the Company will not differ materially from those expressed or implied by such forward-looking statements.  Factors that could cause actual events or results to differ significantly from those described in the forward-looking statements include, but are not limited to those described in the cautionary language included under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011, the Company’s Quarterly Report for the fiscal quarter ended March 31, 2012 and other filings made with the SEC.

About Hampton Roads Bankshares

Hampton Roads Bankshares, Inc. is a bank holding company that was formed in 2001 and is headquartered in Norfolk, Virginia. The Company’s primary subsidiaries are Bank of Hampton Roads, which opened for business in 1987, and Shore Bank, which opened in 1961 (the “Banks”). The Banks engage in general community and commercial banking business, targeting the needs of individuals and small to medium-sized businesses. Currently, Bank of Hampton Roads operates banking offices in Virginia and North Carolina doing business as Bank of Hampton Roads and Gateway Bank & Trust Co. Shore Bank serves the Eastern Shore of Maryland and Virginia through seven banking offices, ATMs and a recently opened loan production office in West Ocean City, Maryland. Through various affiliates, the Banks also offer mortgage banking services and investment products. Shares of the Company’s common stock are traded on the NASDAQ Global Select Market under the symbol “HMPR.” Additional information about the Company and its subsidiaries can be found at www.hamptonroadsbanksharesinc.com.

CONTACT: Stephen P. Theobald
         Executive Vice President and
         Chief Financial Officer
         (757) 217-1000

Quaterra (QMM) Announces Increase in Silver Resource at Nieves, Mexico

VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 06/27/12 — Quaterra Resources Inc. (TSX VENTURE:QTA)(NYSE MKT:QMM)(NYSE Amex:QMM) and 50% joint-venture partner Blackberry Ventures 1, LLC, today announced that an updated independent resource estimate has substantially increased contained silver ounces at their Nieves property in northern Zacatecas, Mexico.

The NI 43-101-compliant resource was completed by Caracle Creek International Consulting Inc. of Toronto, Canada, and supersedes a previous resource estimate released in August 2010.

Nieves’ updated indicated resource of 33.04 million tonnes averaging 50.1 g/t silver (1.61 oz/ton) contains 53.22 million ounces of silver at a base case cutoff grade of 15 grams. The new resource represents a 328% increase in tonnes, a 194% increase in contained silver ounces and a 31.2% decrease in grade compared with the previous August 2010 estimate. The inferred resources at La Quinta and North total over 58.0 million tonnes averaging 30.4 g/t silver (0.98 oz/ton) containing an additional 56.7 million ounces of silver. This is a 20.4% increase in tonnes, a 15.3% decrease in contained silver ounces and a 29.5% decrease in grade.

          Concordia and San Gregorio vein systems, Nieves Property          

                  Estimated mineral resources, June 2012(1)
----------------------------------------------------------------------------
                                      Tonnes    Ag    Au          Ag      Au
Vein       Zone    Classification     (t)(2) (g/t) (g/t)     (oz)(3) (oz)(3)
----------------------------------------------------------------------------
           La
Concordia   Quinta Indicated      33,038,000  50.1  0.04  53,216,700  42,500
----------------------------------------------------------------------------
           La
Concordia   Quinta Inferred       39,258,000  32.0  0.02  40,390,300  25,200
----------------------------------------------------------------------------
San
 Gregorio  North   Inferred       18,769,000  27.0  0.08  16,292,800  48,300
----------------------------------------------------------------------------
1) Prepared by Jason Baker, P.Geo., Geological Engineer, Caracle Creek
   International Consulting Inc., an independent Qualified Person within the
   meaning of NI 43-101, using a reporting cut-off grade of 15 g/t Ag. Au is
   reported to 2 decimal places and Ag to 1 decimal place.
2) Tonnes rounded to the nearest 1,000.
3) 1 troy ounce = 31.103 grams.

The 15-gram cutoff used in the current study is substantially lower than the 45-gram cutoff used in the 2010 report and reflects the fact that much of the mineralization is shallow and may be amenable to open pit mining. The new resource will be used in the preparation of a Preliminary Economic Analysis (PEA) to be completed by M3 Engineering in the third quarter of this year.

At a 45-gram cutoff the indicated resource increased 181% to 12.9 million tonnes; the contained silver increased 134% to 35.7 million ounces; and the grade decreased 16.7% to 86.1 g/t. (A summary of indicated and inferred resources at various cutoff grades is shown in Table 1-1 at the end of this news release).

The Caracle Creek report concludes that the phase seven and eight drill programs increased the total length of the Concordia vein mineralized zone to 1,300 meters and also demonstrated the presence of up-dip near-surface mineralization. The report recommends additional specific gravity measurements at San Gregorio North (in progress); infill drilling at both La Quinta and San Gregorio North which can increase the amount of indicated resource and possibly increase the grade; additional drilling along the California vein; and drill testing of new geophysical targets.

Also, recent mapping and sampling at West Santa Rita, located over 500 meters from Quaterra’s nearest drill hole, is encouraging. Two groups of narrow, sub-parallel two to 30 centimeter wide calcite-quartz veinlets have been identified, some of which contain strong gold and silver mineralization (for details see below).

“We are very pleased that our earlier optimism has been vindicated and that the size of the resource at Nieves has grown substantially,” says Quaterra’s President and CEO, Tom Patton. “We believe a resource of this size has potential to support a large open pit operation. Also, the high gold geochemistry at West Santa Rita provides the possibility of additional upside moving forward.”

Resource Estimation Methodology

Drill hole collar coordinates and details were provided in MS Excel format by Quaterra including assays, lithology and down hole survey. The resource estimate was calculated using data from 13 drill holes from programs of previous operators between 1999 and 2000, as well as 183 drill holes drilled by Quaterra between 1999 and 2012. QA/QC was completed by Caracle Creek on the assays prior to incorporation in the 3D model.

All of these data were compiled into a database which links directly to the geological modelling and resource estimation software. 3D wireframes (solids) representing the mineralized areas were constructed and used to constrain (domain) the tonnage and grade estimation. GEMCOM’s GEMS software V.6.3 was used to generate the 3D block model and perform the grade estimation. Specific Gravity (SG) for the Concordia (La Quinta) area was determined using 173 SG samples within the mineralized domain. The block model was populated with SG values using these 173 SG samples via inverse distance interpolation. There were only 16 SG samples available for the San Gregorio North area, therefore, the average of those samples (2.83) was assigned to each block. Grades for Ag & Au were estimated using the anisotropic inverse distance method of interpolation. Missing assay intervals were interpolated through and not assigned zero grades. The following table shows the search ellipse parameters used in the grade estimation for both the Concordia and San Gregorio areas:

----------------------------------------------------------------------------
           Major     Semi-major          Minor
          Search         Search         Search      Principal
Pass      Radius         Radius         Radius        Azimuth            Dip
----------------------------------------------------------------------------
1           100m           100m            50m      0 degrees     60 degrees
2           200m           200m           100m      0 degrees     60 degrees
----------------------------------------------------------------------------

----------------------------------------------------------------------------
           Intermediate            Min #            Max #             Search
Pass            Azimuth          Samples          Samples               Type
----------------------------------------------------------------------------
1            75 degrees                5               30          Octant(1)
2            75 degrees                2               30     Ellipsoidal(2)
----------------------------------------------------------------------------
(1) An Octant type search divides the search ellipse into eight (8) octants.
    Four (4) of the eight (8) Octants must have contained data in order for
    the block to be populated with a maximum of 5 samples per octant.
(2) An Ellipsoidal search simply populates the block with all data contained
    within the search ellipse dimensions.

For the Concordia (La Quinta) area, blocks populated during pass 1 were classified as indicated and blocks populated during pass 2 were classified as inferred. For the San Gregorio North area, all blocks were classified as inferred due to the lack of SG data available for the area. The ellipsoids were orientated by principal azimuth, dip and intermediate azimuth (where positive rotation around the X-axis is from Y towards Z, around the Y-axis is Z towards X, and around the Z-axis is X towards Y).

Independent, NI 43-101-compliant resources at the Quaterra Nieves Property were estimated by Jason Baker, P.Eng., (APENS#9627), a Geological Engineer with CCIC and an independent qualified person as defined by NI 43-101. Zsuzsanna Magyarosi Ph.D., P.Geo. (APGO#2031), also of CCIC, is the independent qualified person responsible for the QA/QC evaluation. The mineral resources are reported in accordance with National Instrument 43-101 and have been estimated in compliance with generally accepted CIM “Estimation of Mineral Resource and Mineral Reserves Best Practices” guidelines. Block model quantities and grade estimates for the Nieves Property were classified according to the latest CIM Definition Standards for Mineral Resources and Mineral Reserves.

2012 Geophysics and Geochemistry

Geophysical surveys completed during the first quarter of 2012 included six lines (28.4 line-kilometers) of vector controlled source audio-magnetotellurics and induced polarization (CSAMT/CSIP), and nine follow-up lines of pole/dipole induced polarization (IP) totaling 16.5 line-kilometers. The six lines of vector CSAMT/CSIP were spaced 400 meters apart and covered 1,000 hectares west of the main veins in the area of an enigmatic magnetic low. Nine anomalous zones were detected and validated with IP lines using 50-meter dipole spacings. Most of the anomalies appear to be westward extensions of mineralized veins previously drilled, including the Dolores, Santa Rita, Nino and Orion veins.

The most interesting area identified to date is West Santa Rita, located 600 to 800 meters southwest of the main Santa Rita mine and over 500 meters from Quaterra’s nearest drill hole. Mapping and sampling have identified two groups of narrow, sub-parallel two to 30 centimeter wide calcite-quartz veinlets, some of which contain strong gold and silver mineralization. A total of 39 rock chip samples contain gold values ranging from less than 0.05 ppm to 8.11 ppm, with six of the samples above 2 ppm. Silver values range from less than 0.02 ppm to 253 ppm, with seven samples at or above 29 ppm. Lead and zinc range from 2 ppm and 7 ppm to 4,460 ppm and 2,690 ppm respectively.

Locally, high levels of pathfinder elements arsenic, mercury and antimony suggest that the veinlets may represent high-level leakage, an idea supported by the presence of geophysical anomalies (chargeability highs and resistivity lows) starting at a depth of 50 to 100 meters below surface. Additional lines of in-fill IP and subsequent drilling of the most prospective coincident geophysical and gold-silver anomalies will be completed later this summer.

Jason Baker, of Caracle Creek International Consulting Inc., is the Qualified Person responsible for the resource section of this release. Eugene Spiering is the Qualified Person responsible for the geophysics and geochemistry section of the release.

On behalf of the Board of Directors,

Thomas Patton, President and CEO, Quaterra Resources Inc.

Should you wish to receive news releases by fax please provide your contact details to Quaterra at 604-681-9059 (direct), 1-855-681-9059 (toll free) or email info@quaterra.com.

Disclosure note

The results of the Caracle Creek International Consulting Inc. of Toronto resource estimate have been reviewed by Quaterra technical staff. The Company believes that the Caracle Creek resource estimate for the Nieves Silver Project was conducted in a professional and competent manner. Inferred resources are resources that have not been defined in sufficient detail to be characterized as Measured or Indicated resources. Mineral resources have not had economic considerations applied to them and are therefore not characterized as Reserves.

The mining terms “indicated resource” and “inferred resource” are used in this news release in accordance with Canadian regulations but are not recognized by the United States Securities and Exchange Commission. For clarification, the Company has no properties that contain “reserves” as defined by the SEC and is providing the forgoing, in part, in order to meet its requirements under National Instrument 43-101 adopted by the BC Securities Commission and the Canadian Securities Administrators.

Some statements contained in this news release are forward-looking statements within the safe harbor of the Private Securities Litigation Reform Act of 1995. These statements generally are identified by words such as the Company “believes”, “expects”, and similar language, or convey estimates and statements that describe the Company’s future plans, objectives or goals. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Further information regarding risks and uncertainties which may cause results to differ materially from those projected in forward-looking statements, are included in filings by the Company with securities regulatory authorities. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. The Company does not undertake to update any forward-looking statement that may be made from time to time except in accordance with applicable securities laws. References may be made in this press release to historic mineral resource estimates. None of these are NI 43-101 compliant and a qualified person has not done sufficient work to classify these historic estimates as a current mineral resource. They should not be relied upon and Quaterra does not treat them as current mineral resources.

Cautionary Note to U.S. Investors – The United States Securities and Exchange Commission permits U.S. mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms on this website (or press release), such as “measured”, “indicated”, and “inferred” “resources”, which the SEC guidelines generally prohibit U.S. registered companies from including in their filings with the SEC. U.S. Investors are urged to consider closely the disclosure in our Form 40-F which can be requested from us, and is available on our website at www.quaterra.com and at www.sec.gov/edgar.shtml.

Expanded information on the Company’s projects is described on our website at www.quaterra.com.

Table 1-1: Nieves Updated Mineral Resource, June 2012

                       Estimated mineral resources(1)                       

          Concordia and San Gregorio vein systems, Nieves Property
----------------------------------------------------------------------------
Ag
Range                                 Classifi-       Tonnes      Ag      Au
(g/t)          Vein         Zone      cation          (t)(2)   (g/t)   (g/t)
----------------------------------------------------------------------------
greater than
 5.0           Concordia    La Quinta Indicated   49,530,000    36.7    0.03
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred    67,235,000    22.6    0.02
----------------------------------------------------------------------------
               San Gregorio North     Inferred    56,827,000    14.8    0.06
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 15.0          Concordia    La Quinta Indicated   33,038,000    50.1    0.04
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred    39,258,000    32.0    0.02
----------------------------------------------------------------------------
               San Gregorio North     Inferred    18,769,000    27.0    0.08
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 25.0          Concordia    La Quinta Indicated   23,420,000    62.6    0.05
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred    22,053,000    41.5    0.02
----------------------------------------------------------------------------
               San Gregorio North     Inferred     7,349,000    39.8    0.11
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 35.0          Concordia    La Quinta Indicated   17,188,000    74.6    0.05
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred    12,469,000    50.7    0.02
----------------------------------------------------------------------------
               San Gregorio North     Inferred     3,711,000    50.1    0.13
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 45.0          Concordia    La Quinta Indicated   12,906,000    86.1    0.06
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred     7,104,000    58.8    0.03
----------------------------------------------------------------------------
               San Gregorio North     Inferred     2,070,000    58.6    0.15
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 75.0          Concordia    La Quinta Indicated    6,233,000   116.5    0.07
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred     1,053,000    92.5    0.05
----------------------------------------------------------------------------

----------------------------------------------------------------------------

----------------------------------------------------------------------------
Ag
Range                                 Classifi-             Ag            Au
(g/t)          Vein         Zone      cation           (oz)(3)       (oz)(3)
----------------------------------------------------------------------------
greater than
 5.0           Concordia    La Quinta Indicated     58,433,200        47,800
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred      48,854,500        43,200
----------------------------------------------------------------------------
               San Gregorio North     Inferred      27,040,600       109,600
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 15.0          Concordia    La Quinta Indicated     53,216,700        42,500
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred      40,390,300        25,200
----------------------------------------------------------------------------
               San Gregorio North     Inferred      16,292,800        48,300
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 25.0          Concordia    La Quinta Indicated     47,137,000        37,600
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred      29,425,000        14,200
----------------------------------------------------------------------------
               San Gregorio North     Inferred       9,404,000        26,000
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 35.0          Concordia    La Quinta Indicated     41,225,500        27,600
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred      20,325,400         8,000
----------------------------------------------------------------------------
               San Gregorio North     Inferred       5,978,000        15,500
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 45.0          Concordia    La Quinta Indicated     35,727,500        24,900
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred      13,430,800         6,900
----------------------------------------------------------------------------
               San Gregorio North     Inferred       3,899,100        10,000
----------------------------------------------------------------------------

----------------------------------------------------------------------------
greater than
 75.0          Concordia    La Quinta Indicated     23,345,800        14,000
----------------------------------------------------------------------------
               Concordia    La Quinta Inferred       3,130,800         1,700
----------------------------------------------------------------------------

----------------------------------------------------------------------------
1) Prepared by Jason Baker, P.Geo., Caracle Creek International Consulting
   Inc., an independent Qualified Person within the meaning of NI 43-101,
   showing tonnes in various Ag ranges. Au is reported to 2 decimal places
   and Ag to 1 decimal place.
2) Tonnes rounded to the nearest 1,000.
3) 1 troy ounce = 31.103 grams. Ounces have been rounded to the nearest 100.

The TSX Venture Exchange and the American Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the contents of this news release, which has been prepared by management.

Contacts:
Quaterra Resources Inc.
Thomas Patton
President and CEO
604-641-2758

Quaterra Resources Inc.
Lauren Stope
Manager Communications
604-641-2746
info@quaterra.com

Synergetics USA (SURG) Announces FDA Clearance of VersaVIT™ Vitrectomy System

O’FALLON, MO — (Marketwire) — 06/27/12 — Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures and markets innovative microsurgical devices for ophthalmic and neurosurgical applications, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VersaVIT™, a novel vitrectomy system for the retinal surgery market.

“The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics’ strategy to enter into higher growth areas of retinal surgery,” said David M. Hable, President and CEO. “We believe that VersaVIT is a ‘game changer’ given its functionality, portability and competitive pricing relative to traditional vitrectomy systems.” The Company is awaiting CE mark approval, which has been submitted and is currently under review.

About Synergetics USA, Inc.

Synergetics USA, Inc. (“Synergetics USA” or the “Company”) is a leading supplier of precision surgical devices. The Company’s primary focus is on the surgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company’s product lines focus upon precision engineered, disposable and reusable devices, procedural kits, and the delivery of various energy modalities for the performance of less invasive surgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company’s website address is www.synergeticsusa.com.

Forward-Looking Statements

Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in Synergetics’ Annual Report on Form 10-K for the year ended July 31, 2011, as updated from time to time in our filings with the Securities and Exchange Commission.

SYNERGETICS USA, INC.
3845 Corporate Centre Drive
O’Fallon, Missouri 63368
(636) 939-5100
http://www.synergeticsusa.com
Attn: Pamela G. Boone
Chief Financial Officer

Nanosphere (NSPH) Receives FDA Authorization to Market Its Gram-Positive Blood Culture Test

First of Its Kind Test to Launch Immediately

NORTHBROOK, Ill., June 27, 2012 (GLOBE NEWSWIRE) — Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today the U.S. Food and Drug Administration has granted a de novo petition permitting marketing of its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on the automated sample-to-result Verigene^® System.

The BC-GP test notably expands Nanosphere’s infectious disease test capabilities to include fast detection of bacteria that can cause deadly bloodstream infections, an increasingly recognized health threat.

With a single automated test, the Verigene BC-GP test provides fast genus and species level detection for a broad panel of clinically significant gram-positive bacteria. The BC-GP test also detects several crucial markers for antimicrobial resistance, including the mecA, vanA, and vanB genes, which confer resistance to the antibiotics methicillin/oxacillin and vancomycin. Rapid detection of these antimicrobial resistance markers provides vital information for clinicians to determine the best treatment for bloodstream infections.

“With the BC-GP test, patients suspected of deadly infections can now get a first-ever diagnostic tool for detecting disease-causing bacteria while simultaneously determining antibiotic resistance within the critical timeframe for making and adjusting initial treatment,” said William Moffitt, Nanosphere’s Chief Executive Officer.

The BC-GP test provides identification of bacteria and antimicrobial resistance genes from gram-positive blood culture bottles within two and a half hours, as compared with current microbiological methods, which can take up to two to three days.

Rapid and accurate identification of bacteria and resistance markers is critical in guiding appropriate antibiotic treatment. Studies show delayed administration of appropriate antibiotics is associated with a 7.6% decrease in survival rate for each hour therapy is delayed.¹ Rapid molecular testing of blood cultures reduces this time, with associated hospital cost savings of up to $21,000 per patient.²

The sample-to-result BC-GP test automates the steps of bacterial DNA extraction and target detection on the Verigene System.

The ease-of-use and fast turnaround time of the BC-GP test allow hospitals of any size to benefit from the speed and accuracy of automated molecular testing. In addition to its gram-positive blood culture test, Nanosphere is currently developing a test for gram-negative blood cultures that will provide genus, species, and resistance detection on the same automated platform. These tests are part of a comprehensive infectious disease test menu, including the multiplexed Verigene RV+ respiratory virus test cleared by the FDA in 2011, as well as tests for C. difficile and a panel of enteric bacterial and viral pathogens that Nanosphere plans to submit for FDA clearance in 2012.

About Bloodstream Infections

Septicemia is associated with more than 1.6 million hospitalizations per year in the United States and is the most expensive cause of hospitalization totaling $15.4 billion in aggregate hospital costs.³ Septicemia occurs when a pathogenic microorganism, usually a bacterium or a fungus, enters the bloodstream and causes an inflammatory immune response. Because bloodstream infections and septicemia are pervasive problems associated with high mortality rates, timely delivery of appropriate treatment is essential.

Bloodstream infections with gram-positive bacteria are often complicated by antimicrobial resistance. The inability to rapidly identify resistant strains of pathogenic bacteria has led to antimicrobial use that is often ineffectual, wasteful, or bears risk of proliferating resistant strains. Rapid identification of both organism and resistance is essential to implementing efficient and appropriate therapy.⁴

Gram-positive bacteria are also a common source of contamination during blood draws. Contaminant species are frequently responsible for false-positive blood cultures that lead to inappropriate antimicrobial use.⁵ Patients with contaminated blood culture bottles are often presumptively treated for bloodstream infections for several days until the organism can be identified as a contaminant using conventional biochemical methods. Patients with false-positive blood culture results triggered by contaminants have hospitalization costs more than $8,000 higher than patients with true negative blood culture results.⁶ Due to the large burden of infections and contaminants due to gram-positive bacteria, rapid identification of bacteria isolated from blood cultures is a primary healthcare concern.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, for multiplexed infectious disease, genetic, and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple, and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.

For additional information regarding Nanosphere’s infectious disease products, please contact Nanosphere at IDtesting@nanosphere.us or visit www.nanosphere.us.

The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344

References

1. Kumar A, Roberts D, Wood KE. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.
2. Bauer KA, West JE, Balada-Llasat J, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis. 2010;51(9):1074-80.
3. Elixhauser A, Friedman B, Stranges E. 2011. Septicemia in US Hospitals, 2009. HCUP Statistical Brief #122. Agency for Healthcare Research and Quality.
4. Sahm DF, Free L, Smith C, Eveland M, Mundy LM. Rapid Characterization Schemes for Surveillance Isolates of Vancomycin-Resistant Enterococci. J Clin Microbiol. 1997;8:2026-2030.
5. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Ag Chemo. 1995;39:268-270.
6. Zwang O, Albert, RK. Analysis of Strategies to Improve Cost Effectiveness of Blood Cultures. Journal of Hospital Medicine, 1:272-276.

CONTACT: Nanosphere, Inc.
         Roger Moody
         (847) 400-9021
         IDtesting@nanosphere.us

         Media and investors:
         The Torrenzano Group
         Denise Roche
         212-681-1700
         droche@torrenzano.com

Entropic Communications (ENTR) Sees Upside to Revenue and EPS in Q2

Strength in Connectivity Products and Improvements to Set-Top Box System-on-a-Chip (SoC) Supply Chain Constraints Drive Better Than Expected Revenue Growth

SAN DIEGO, June 27, 2012 (GLOBE NEWSWIRE) — Entropic Communications, Inc. (Nasdaq:ENTR), a world leader in semiconductor solutions for the connected home, announced today expected revenue in the second quarter of 2012 will be stronger than the Company’s previous outlook, which was provided on April 24, 2012.

Entropic now expects second quarter revenue to range between $81 million and $82 million. The Company’s previous guidance for the second quarter was for revenue to range between $75 million and $77 million.

“We are seeing better than expected results for our Connectivity products with strong HD attach rates and upgrades at Tier-1 Pay-TV service providers driving increased demand for our home networking and direct broadcast satellite solutions,” said Patrick Henry, president and chief executive officer, Entropic Communications.  “Also, through impressive execution by our operations team and supply chain partners, we were able to resolve some key supply chain constraints related to our set-top box SoC business ahead of schedule; leading to higher revenue for the set-top box SoC products versus our initial expectations entering the quarter.”

The Company expects GAAP earnings per share for the second quarter of approximately $0.00 and non-GAAP earnings per share of approximately $0.08. The Company’s previous guidance was for non-GAAP earnings per share of $0.03.

Entropic expects to release financial results for the second quarter 2012, and host a conference call for analysts and investors on August 1, 2012.  At that time, the Company will review its quarterly results and provide an outlook for the third quarter of 2012.  Details on the conference call will be announced, prior to that date.

About Entropic Communications

Entropic Communications, Inc. (Nasdaq:ENTR) is a leading global provider of silicon and software solutions to enable connected home entertainment. The Company transforms how traditional HDTV broadcast and streaming video content is seamlessly, reliably, and securely delivered, processed, and distributed into and throughout the home. Entropic’s next-generation home connectivity and set-top box system-on-a-chip (SoC) solutions enable Pay-TV service providers to offer consumers a more captivating whole-home entertainment experience by delivering new, high-performing ways to connect, engage, and enjoy multimedia content. For more information, visit Entropic at: www.entropic.com.

The Entropic Communications logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4255

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature constitute “forward-looking statements.”  Such statements include, but are not limited to, statements regarding our expected revenue, and second quarter net income per share, as well as statements regarding HD attach rates and increased demand for the company’s solutions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Entropic’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  These factors include, but are not limited to, our dependence on a limited number of supply chain partners for the manufacture of our products and other factors that could affect our ability to meet customer demand; our dependence on a limited number of customers for a substantial portion of our revenues; risks associated with adverse U.S. and international economic conditions; the ability of our customers or the service providers who purchase their products to successfully compete and continue to grow in their markets; the continued development of the market for HD video and other multi-media content delivery and networking solutions; risks associated with competing against larger and more established companies and our ability to compete successfully in the connected home entertainment market; risks associated with timely development and introduction of new or enhanced products; risks related to international operations; and other factors discussed in the “Risk Factors” section of Entropic’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012.  All forward-looking statements are qualified in their entirety by this cautionary statement. Entropic is providing this information as of the date of this release and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Copyright © 2012 Entropic Communications, Inc. All rights reserved. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners.

CONTACT: Investor Contact:
         Debra Hart
         +1 858.768.3852
         debra.hart@entropic.com

         Media/Industry Analyst Contact:
         Chris Fallon
         +1 858.768.3827
         chris.fallon@entropic.com

GlobalWise (GWIV) Reports on International Expansion Initiatives

COLUMBUS, OH — (Marketwire) — 06/27/12 — GlobalWise Investments, Inc. (OTCBB: GWIV) (OTCQB: GWIV) (www.GlobalWiseInvestments.com) and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today comments on the Company’s progress to date and near term intentions to expand into international markets.

Since 1994, Intellinetics has focused primarily on domestic United States markets, selling ECM software services through a traditional, direct sales force. This strategy served Intellinetics well in the previous 18 years, but the original father-son management team of Matthew and Michael Chretien saw the opportunity to expand the business by hiring Lexmark International executive William J. “BJ” Santiago. Mr. Santiago was brought on to lead the new cloud-based ECM software enterprise and expand the Company’s distribution through a one-to-many strategy utilizing Channel Partners who already have a tested and proven model to sell hardware or software related services.

In 2012 alone, eight new Channel Partners have been brought on to continue software sales expansion in the United States, as well as pursue new opportunities internationally. This Channel Partner strategy has shown it is possible to distribute ECM software services in every industry. By utilizing distribution partners who already have an extensive sales force and customer base, GlobalWise is able to focus on being a software company while the Partners emphasize client sales and on-going support.

Recently, the Company announced an agreement with SOIN Integrales (www.soin.co.cr), headquartered in Costa Rica, who dominates the Latin America market selling high-end ERP solutions from companies like Oracle, SAP and Sybase. Historically, SOIN did not have an ECM (Enterprise Content Management) practice within their software product offerings. However, similar to the US, Latin America is rapidly adopting digital management of document and records for compliance and privacy regulation and historically did not have a cost effective ECM solution.

Today, through the Intellinetics On-demand Solution Store™ templates, SOIN can capitalize on this untapped small to medium sized client base through an exclusive agreement with Intellinetics. Over the past several months, the companies have worked closely together to translate the Intellivue™ software and related product collateral into Spanish and are currently marketing the software services. The initial Intellivue™ solution and product launch has begun in Mexico, Costa Rica, Panama, El Salvador and Nicaragua.

As well, the Intellinetics agreement with MWAi will begin the Company’s first foray into English speaking countries in Europe, with expansion expected to begin in the third quarter of 2012. Since Intellinetics has invested heavily in their template based best practice ECM solutions for a variety of industries, the current software will need very little upgrading aside from potential cultural differences. Even more exciting for Intellinetics and MWAi is the on-going efforts to convert the Intellivue™ cloud-based ECM software into a double-byte character set (DBCS), a software language typical for Japanese, Korean and Chinese translations. By employing DBCS, the Intellinetics software suite will be ready for clients in the Asia-Pacific Rim later this year.

“GlobalWise is positioning itself for record-breaking growth for the balance of 2012 and 2013,” stated William. J. “BJ” Santiago, CEO of GlobalWise. “We have and will continue to recruit many strategic Partners to help us access more industries and markets. I expect we will have additional announcements in the near future regarding further domestic and international growth.”

“The great news with a cloud-based service delivery model, now available in both English and Spanish and soon for the Asian market, is the multitudes of ways to get our software into the hands of clients,” continued Mr. Santiago. “Whether it’s integrating the ECM capabilities into an existing CRM or ERP system, implementation with multi-function printers or sold as a stand-alone solution, our software is dynamic enough to sit alongside almost any other architecture. The cloud delivery model provides a lower cost delivery approach without major capital expenditures that is perfect in the emerging ECM markets that previously did not have a cost effective solution.”

About GlobalWise Investments, Inc.

GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company’s flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape — virtually anything that can be digitized — in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.

For additional information, please visit the Company’s corporate website: www.GlobalWiseInvestments.com

This press release may contain “forward-looking statements.” Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.

GlobalWise Investments, Inc.
Columbus, Ohio
www.GlobalWiseInvestments.com
614-388-8909
Contact@GlobalWiseInvestments.com

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975

BioMimetic (BMTI) and Chelsea Therapeutics Recent Performers in a Thriving Industry

NEW YORK, NY — (Marketwire) — 06/25/12 — Despite the recent economic turmoil in Europe, the Biotech Industry has been home to some of the strongest performers in the market in 2012. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index ETF (FBT) year-to-date are up 30 percent and 31 percent, respectively. As the world continues to face evolving health challenges the discoveries of new therapeutics and vaccines are critical. Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) and Chelsea Therapeutics International Ltd. (NASDAQ: CHTP).

Access to the full company reports can be found at:

www.FiveStarEquities.com/BMTI

www.FiveStarEquities.com/CHTP

Expiring patents have been a major dilemma for pharmaceutical companies. New products that are being introduced are not expected to generate the same level of revenues of the products that have lost patent protection. The Obama administration is currently analyzing a proposal in which the exclusivity period for biologics would be cut down by 5 years. Mergers & Acquisitions activity is expected to pick up in 2012 as companies scramble to look to make up for loss revenues. M&A allow companies to acquire products that are already proven in the market place without the hassle and costs associated with research and development.

“Many of the pharmaceutical companies started producing everything in-house out of their own R&D organizations and over time they’ve failed to produce enough that way. So the industry is now coalescing around a 50-50 model of half on your own and half bought in. There are some things we’ll do for ourselves but we need to be constantly on the lookout for new technologies,” said Angus Russell, Chief Executive of Shire PLC.

Five Star Equities releases regular market updates on companies in the Biotech Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports and industry newsletters.

BioMimetic Therapeutics is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedics, sports medicine and spine applications.

Chelsea Therapeutics specializes in the acquisition and development of innovative products and technologies that address important unmet medical needs or offer alternatives to current methods of treatment. The company recently reported positive data from two phase 3 trials showed that patients treated with Northera (droxidopa) experienced improvements in their symptoms of Neurogenic Orthostatic Hypotension.

Five Star Equities provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. Five Star Equities has not been compensated by any of the above-mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at:

www.FiveStarEquities.com/disclaimer

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Five Star Equities
Email Contact

Basis Design and Socket Mobile (SCKT) Provide iOS Barcode Scanning for Symantec’s Altiris

NEWARK, CA — (Marketwire) — 06/25/12 — Socket Mobile, Inc. (NASDAQ: SCKT), an innovative provider of mobile productivity solutions, today announced that Basis Design — a leading developer of enterprise level software solutions — has certified the Socket Bluetooth® Cordless Hand Scanner™ (CHS) as the barcode scanner of choice for its Barcode Essentials application for the iPad, iPhone and iPod touch.

Barcode Essentials is used in conjunction with the Altiris Barcode Solution from Symantec, to provide mobile barcoding support to Symantec’s Altiris IT Management Suite and Altiris Asset Management Suite. IT organizations in healthcare, finance, government and other industries use the suites to track costly assets throughout their lifecycle and ensure that current infrastructures can support new technology changes and adapt to changing processes and business needs.

“Many Altiris Barcode customers today use stationary consoles to scan asset tags on IT equipment,” said Andrew Peterson, managing director at Basis Design. “With our new Barcode Essentials iOS app and Socket’s highly mobile barcode scanners, Altiris customers now have a far superior option for scanning asset tags wherever equipment is deployed, using affordable Apple devices already popular among IT professionals.”

“Applications like Barcode Essentials demonstrate the business demand for high-performance yet affordable barcode reading solutions for Apple devices,” said Mike Gifford, executive vice president at Socket Mobile. “With the recent release of our CHS 7Ci low-cost, Apple certified 1D barcode scanner, we expect more enterprise developers like Basis Design to use our SocketScan 10 Software Development Kit (SDK) to add barcode scanning support to their apps.”

Besides the CHS 7Ci, Barcode Essentials also offers native iOS support to the Socket CHS 7Xi and 7XiRx Apple certified 2D barcode scanners. To learn more, visit the Socket Mobile website or contact sales@socketmobile.com.

Barcode Essentials is available in Free and Standard editions for download in the Apple App Store. Customers must have an existing Altiris Barcode Solution license from Symantec in order to sync Barcode Essentials with their server.

About Basis Design
Since 1999, Basis Design has been developing enterprise level software solutions and mobile applications that help clients automate business processes, control costs, gain stronger market share and drive revenue. Basis is headquartered in Turramurra, New South Wales, Australia, and can be reached at 61 2 9440 9516 or www.basis.com.au.

About Socket Mobile
With 20 years of experience in the Automatic Identification and Data Capture (AIDC) market, Socket makes mobile computing and productivity work. The company offers a family of handheld computers and an extensive portfolio of AIDC peripherals specifically designed to increase productivity and drive operational efficiencies in healthcare, hospitality and other business mobility deployments. The company also offers OEM solutions for the mobile device market. Socket is headquartered in Newark, Calif. and can be reached at 510-933-3000 or www.socketmobile.com. Follow Socket Mobile on Twitter @socketmobile and subscribe to sockettalk.socketmobile.com, the company’s official blog.

Socket Bluetooth® Cordless Hand Scanner is a trademark of Socket Mobile. All other trademarks and trade names contained herein may be those of their respective owners.

© 2012, Socket Mobile, Inc. All rights reserved.

Dex One (DEXO) Announces Alan F. Schultz Elected Chairman

Dex One Corporation (NYSE: DEXO) announced today that current director Alan F. Schultz has been elected Chairman of the Board of Directors. He succeeds Eugene I. Davis who has resigned from the Dex One Board.

About Dex One Corporation

Dex One Corporation (NYSE: DEXO) is a leading marketing solutions provider helping local businesses and their customers connect wherever and whenever they choose to search. Building on its heritage of delivering print-based solutions, the company provides integrated products and services to help its clients establish their digital presence and generate leads. Dex One’s locally based marketing experts offer a broad network of local marketing solutions including online, mobile and print search solutions, such as DexKnows.com. For more information, visit www.DexOne.com.

Reliv International (RELV) Named One of St. Louis’s Top Workplaces

Program honors companies with high level of organizational health

Advanced Photonix (API) to Webcast Q4 and Fiscal 2012 Earnings Conference Call

Advanced Photonix, Inc.® (NYSE Amex: API) will announce its FY2012 fourth quarter and fiscal 2012 year end (ending March 31, 2012) financial results on Friday, June 29, 2012. The company will host a conference call at 4:30pm EDT.

Participating in the call will be Richard Kurtz (Chairman and CEO), Rob Risser (COO), and Jeff Anderson (CFO). A question and answer period will take place at the end of the discussion. A press release announcing the financial results will be released after the close of the market on the same day.

The conference call will be webcast live and will be accessible at http://investor.advancedphotonix.com. Participants can dial into the conference call at 888.679.8034 (617.213.4847 for international) using the passcode 82301572.

Pre-registrants can obtain a pin number to use when dialing into the live call that will enable quick connection, bypassing the operator. Participants may pre-register at: https://www.theconferencingservice.com/prereg/key.process?key=PAYCGVXNU

An audio replay of the call will be available shortly thereafter on the same day and will remain on-line until July 6, 2012. The replay number is 888.286.8010 (617.801.6888 for international) and the passcode is 83012657.

About Advanced Photonix, Inc.

Advanced Photonix, Inc. ® (NYSE Amex: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical receivers and terahertz instrumentation for telecom, homeland security, military, medical and industrial markets. With our patented technology and state-of-the-art manufacturing we offer industry leading performance, exceptional quality, and high value added products to our OEM customer base. For more information visit us on the web at www.advancedphotonix.com.

The information contained herein includes forward looking statements that are based on assumptions that management believes to be reasonable but are subject to inherent uncertainties and risks including, but not limited to, unforeseen technological obstacles which may prevent or slow the development and/or manufacture of new products; potential problems with the integration of the acquired company and its technology and possible inability to achieve expected synergies; obstacles to successfully combining product offerings and lack of customer acceptance of such offerings; limited (or slower than anticipated) customer acceptance of new products which have been and are being developed by the Company; and a decline in the general demand for optoelectronic products. API-G

Overland Storage (OVRL) Patents Valid, ITC Affirms

SAN DIEGO, CA — (Marketwire) — 06/25/12 — Overland Storage (NASDAQ: OVRL) today announced that Administrative Law Judge Charles Bullock of the U.S. International Trade Commission (“ITC”) has issued a 125-page, full version of the Initial Determination that explains his reasoning in detail. The full Initial Determination is confidential and only the attorneys in the ITC action are able to review it. However, on June 22, 2012, attorneys for Overland Storage filed an emergency motion with the ALJ to obtain permission to share more information about the full Initial Determination with Overland Storage and the public.

“It has been reported that Judge Bullock’s Initial Determination found no infringement of both of Overland’s asserted patents,” said Sean Cunningham, DLA Piper partner and lead counsel for Overland Storage. “Although we cannot yet disclose any of the details of the full Initial Determination, I can tell you that those reports are inaccurate.”

On June 21, 2012, Overland Storage announced that the ALJ had issued a public notice of an Initial Determination affirming that both of Overland’s asserted patents are valid, but found that BDT had not committed a violation of Section 337 of the Tariff Act of 1930, the statute that governs ITC actions. Section 337 is the statue under which ITC actions are brought for importing or selling of infringing products into the United States. There are additional legal requirements to find a Section 337 violation that are not requirements in finding infringement of a valid patent in a federal district court lawsuit.

“We understand that the full Initial Determination of the ITC contains positive news for our ongoing litigation,” said Eric Kelly, President and CEO of Overland Storage. “I can assure you that Overland plans to continue its lawsuit against BDT both in the ITC and in federal district court.”

Under ITC procedure, the Initial Determination is not a final resolution of an ITC action. After an Initial Determination is issued, the full Commission decides whether to review and modify the ALJ’s Initial Determination. If the Commission decides to review the Initial Determination on the merits, the Commission will issue its decision in a Final Determination. The Commission’s Final Determination is expected by October 22, 2012. Upon completion of the ITC case, Overland Storage plans to pursue monetary damages against BDT in district court.

Overland Storage has scheduled an investor conference call for Thursday, June 28, 2012 at 2 p.m. PDT (5 p.m. ET) to discuss the ongoing litigation and to share any additional details about the ITC action that can be shared at that time. To access the call, dial (877) 941-4774 (+1 (480) 629-9760 outside the United States) and when prompted, provide the pass code “Overland Storage” to the operator. Participants are asked to call the assigned number approximately 10 minutes before the conference call begins. In addition, a live and archived webcast of the conference call will be available over the Internet at www.overlandstorage.com in the Investor Relations section. A replay of the conference call will also be available via telephone by dialing (800) 406-7325 (+1 (303) 590-3030 outside the United States) and entering access code, 4548620#, beginning 8:00 p.m. ET on June 28, 2012 through 11:59 p.m. ET on July 5, 2012.

About Overland Storage

Overland Storage is the trusted global provider of effortless data management and data protection solutions across the data lifecycle. By providing an integrated range of technologies and services for primary, nearline, offline, archival and cloud data storage, Overland makes it easy and cost effective to manage different tiers of information over time. Overland SnapServer®, SnapSAN™, NEO® and REO® solutions are available through a select network of value added resellers and system integrators. For more information, visit http://www.overlandstorage.com/.

Safe Harbor Statement

Except for the factual statements made herein, the information contained in this news release consists of forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believes,” “hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,” “anticipates” and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and our actual results could differ materially from those contained in such statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain and increase sales volumes of our products; our ability to continue to aggressively control costs and operating expenses; our ability to achieve the intended cost savings and maintain quality with our new manufacturing partner; our ability to generate cash from operations; the ability of our suppliers to provide an adequate supply of components for our products at prices consistent with historical prices; our ability to raise outside capital and to repay our debt as it comes due; our ability to introduce new competitive products and the degree of market acceptance of such new products; the timing and market acceptance of new products introduced by our competitors; our ability to maintain strong relationships with branded channel partners; our ability to maintain the listing of our common stock on the NASDAQ Capital Market; customers’, suppliers’ and creditors’ perceptions of our continued viability; rescheduling or cancellation of customer orders; loss of a major customer; general competition and price measures in the market place; unexpected shortages of critical components; worldwide information technology spending levels; and general economic conditions. Reference is also made to other factors detailed from time to time in our periodic reports filed with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this release and we undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Connect with Overland Storage:
Read the Overland blog: http://www.overlandstorage.com/blog
Follow Overland on Twitter: http://www.twitter.com/OverlandStorage
Visit Overland on Facebook: http://www.facebook.com/OverlandStorage

Overland Storage, SnapSAN, SnapServer, NEO Series, REO Series and the Overland logo are trademarks Overland Storage, Inc., that may be registered in some jurisdictions. All other trademarks used are owned by their respective owners.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Investor Relations Contact:
Charles Messman or Todd Kehrli
MKR Group Inc.
323-468-2300

NuPathe (PATH) to Present Migraine Patch Data at American Headache Society Meeting

CONSHOHOCKEN, PA — (Marketwire) — 06/21/12 — NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that the Company will present data on its migraine patch at the upcoming 54th Annual Scientific Meeting of the American Headache Society (AHS), which takes place June 21-24, 2012 in Los Angeles, CA.

The AHS presentations are:

• “Long Term Safety of the Sumatriptan Iontophoretic Transdermal Patch, NP101, For Acute Migraine: A 12 Month, Repeat Use, Open Label Study”: These final study results involving 7,665 patch applications show that NP101 was well-tolerated with an adverse event profile similar to previous NP101 studies.
• “A Phase I, Single Center, Open Label, Randomized, Single-Dose, Two Way Crossover Study to Compare the Pharmacokinetics of Two NP101 Patch Applications (Sumatriptan Iontophoretic Transdermal System) With and Without Controlled Heat”: These data indicate that the addition of heat applied to the patch for the four-hour application time does not increase drug exposure.

All poster presentations are presented at the Hyatt Regency Century Plaza in Los Angeles, CA, from 11:00 am on Thursday, June 21 through 2:15 pm on Saturday, June 23. Authors will stand by their posters to answer questions during the following times: Friday, June 22 from 12:45 pm – 2:00 pm and Saturday, June 23 from 1:00 pm – 2:15 pm. All times are Pacific Daylight Time.

About the Migraine Patch (NP101 or Zelrix)
NP101 is an active, single-use, transdermal patch in development for the treatment of migraine. If approved, it will be the first transdermal patch for the treatment of migraine. The patch actively delivers sumatriptan, the most widely prescribed migraine medication. In three clinical trials involving more than 10,000 applications, NP101 offered patients fast onset and sustained relief of debilitating migraine symptoms including headache pain and migraine-related nausea (MRN). Because NP101 delivers sumatriptan transdermally, it may be an attractive treatment option for many of the approximately seven million migraineurs who might otherwise delay or avoid taking medication due to MRN. In addition, clinical trials suggest that many migraineurs fail to respond consistently to orally administered medications. This may result from a variety of causes including gastroparesis, a slowing of gastric absorption experienced by some migraine sufferers. The patch utilizes SmartRelief™, NuPathe’s proprietary transdermal delivery technology that allows the rapid yet tightly controlled transport of medication through the skin using a process called iontophoresis. As a result and based on clinical trial experience, the patch may offer a low incidence of triptan sensations that include chest tightness, flushing and feelings of pressure and numbness.

About NuPathe
NuPathe Inc. is a biopharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe’s lead product candidate, NP101, is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates based on its LAD™, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201, for the continuous symptomatic treatment of Parkinson’s disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery. NP202, for the long-term treatment of schizophrenia and bipolar disorder, is being developed to address the long-standing problem of patient noncompliance by providing three months of continuous delivery of risperidone, an atypical antipsychotic. NuPathe is actively seeking partnerships to maximize the commercial potential for our pipeline products in the U.S. and territories throughout the world.

For more information about NuPathe, please visit our website and our blog at www.nupathe.com. You can also follow us on StockTwits (stocktwits.nupathe.com), Twitter (twitter.nupathe.com), SlideShare (slideshare.nupathe.com) and LinkedIn (linkedin.nupathe.com).

Contact Information:

Investor Contacts
John Woolford
Westwicke Partners, LLC
(443) 213-0506
john.woolford@westwicke.com

Keith A. Goldan
Vice President & Chief Financial Officer
NuPathe Inc.
(484) 567-0130

Media Contact
Jennifer Guinan
Sage Strategic Marketing
(610) 410-8111

Rite Aid (RAD) Reports First Quarter Fiscal 2013 Results

Rite Aid Corporation (NYSE: RAD) today reported improved financial results for the first quarter ended June 2, 2012.

The company reported revenues of $6.5 billion, a net loss of $28.1 million or $0.03 per diluted share and Adjusted EBITDA of $274.2 million or 4.2 percent of revenues. Results benefited from continued growth in same store sales and an improvement in gross margin.

“Our turnaround efforts continue to be successful as demonstrated by our sixth consecutive quarter of increased same store sales and Adjusted EBITDA,” said Rite Aid Chairman, President and CEO John Standley.

“During the quarter, we saw strong growth in same-store prescription counts while key initiatives like our popular wellness+ customer loyalty program, enhanced Rite Aid brand offerings and ground-breaking Wellness store format continued to gain traction. We’re proud of the hard work and dedication that our entire Rite Aid team has displayed in driving these positive results and look forward to delivering an even better shopping experience to our customers as we move ahead.”

First Quarter Summary

Revenues for the 13-week quarter were $6.5 billion versus revenues of $6.4 billion in last year’s first quarter. Revenues increased 1.2 percent primarily as a result of an increase in same store sales, which were partially offset by store closings.

Same store sales for the quarter increased 2.5 percent over the prior-year period, consisting of a 2.7 percent increase in front end sales and a 2.4 percent increase in pharmacy sales. Pharmacy sales included an approximate 326 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores increased 3.0 percent over the prior year period, which includes the benefit of additional prescriptions resulting from the Walgreens/Express Scripts dispute. Prescription sales accounted for 68.4 percent of total drugstore sales, and third party prescription revenue was 96.6 percent of pharmacy sales.

Net loss was $28.1 million or $0.03 per diluted share compared to last year’s first quarter net loss of $63.1 million or $0.07 per diluted share. Included in the net loss were a $17.8 million or $0.02 per share loss on debt modification resulting from the successful completion of the previously announced refinancing and a $20.9 million or $0.02 per share charge related to a proposed settlement of a series of wage and hour class action lawsuits, neither of which was included in the company’s guidance. The decrease in net loss year over year resulted from an increase in Adjusted EBITDA and decreases in depreciation and amortization expense and lease termination and impairment charges. The company recorded an income tax benefit and corresponding charge in selling, general and administrative expenses (SG&A) of $60.2 million in the quarter related to the settlement of a Brooks Eckerd pre-acquisition tax audit, offset by the reversal of the related Jean Coutu Group tax indemnification asset. The tax benefit and corresponding SG&A charge had no impact on net loss, Adjusted EBITDA, or cash flow.

Adjusted EBITDA (which is reconciled to net loss on the attached table) was $274.2 million or 4.2 percent of revenues for the first quarter compared to $262.9 million or 4.1 percent of revenues for the like period last year. Adjusted EBITDA improved due to an increase in gross profit, driven by increased sales and an improvement in pharmacy gross margin, resulting from an increase in generic prescriptions. The increase in Adjusted EBITDA was partially offset by the increase in litigation expense related to the $20.9 million proposed class action settlement.

In the first quarter, the company relocated 2 stores, remodeled 143 stores and closed 15 stores. Completed wellness remodels at the end of the first quarter totaled 423. Stores in operation at the end of the first quarter totaled 4,652.

Rite Aid Updates Sales, Adjusted EBITDA and Net Loss Guidance for Fiscal 2013

Rite Aid has updated its fiscal 2013 guidance with sales expected to be between $25.3 billion and $25.7 billion and same store sales to range from a decrease of 0.5 percent to an increase of 1.0 percent over fiscal 2012. The reduction in the company’s sales and same store sales guidance is driven by an increase in the projected negative impact of new generic introductions on pharmacy same store sales from 520 to 600 basis points. Rite Aid has also raised the lower end of its Adjusted EBITDA (which is reconciled to net loss on the attached table) guidance to be between $950 million and $1.025 billion and its net loss guidance to be between $103 million and $248 million or a loss per diluted share of $0.13 to $0.29. Capital expenditures are expected to be approximately $300 million.

Conference Call Broadcast

Rite Aid will hold an analyst call at 8:30 a.m. Eastern Time today with remarks by Rite Aid’s management team. The call will be simulcast via the internet and can be accessed through the websites www.riteaid.com in the conference call section of investor information and www.StreetEvents.com. Slides related to materials discussed on the call will be available on both sites. A playback of the call will be available on both sites starting at 12 p.m. Eastern Time today. A playback of the call will also be available by telephone beginning at 12 p.m. Eastern Time today until 11:59 p.m. Eastern Time on June 23, 2012. The playback number is 1-855-859-2056 from within the U.S. and Canada or 1-404-537-3406 from outside the U.S. and Canada with the eight-digit reservation number 88838417.

Rite Aid is one of the nation’s leading drugstore chains with 4,652 stores in 31 states and the District of Columbia. Information about Rite Aid, including corporate background and press releases, is available through Rite Aid’s website at www.riteaid.com.

Statements, including guidance, in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” and “will” and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, our high level of indebtedness and our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our debt agreements, general economic, market and competitive conditions, our ability to improve the operating performance of our stores in accordance with our long term strategy, the efforts of private and public third-party payers to reduce prescription drug reimbursements and encourage mail order, our ability to manage expenses and our investments in working capital, outcomes of legal and regulatory matters and changes in legislation or regulations, including healthcare reform. These and other risks, assumptions and uncertainties are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

See the attached table for a reconciliation of a non-GAAP financial measure, Adjusted EBITDA to net income (loss), the most comparable GAAP financial measure. We define Adjusted EBITDA as net income (loss) excluding the impact of income taxes (and any corresponding reduction of tax indemnification asset), interest expense, depreciation and amortization, LIFO adjustments, charges or credits for facility closing and impairment, inventory write-downs related to store closings, stock-based compensation expense, debt modifications and retirements, sale of assets and investments, revenue deferrals related to our customer loyalty program and other items.

Ampio (AMPE) Successful Type B Pre-IND Meeting with the FDA

Magyar Bank (MGYR) Names Jon R. Ansari Executive Vice President

NEW BRUNSWICK, N.J., June 21, 2012 /PRNewswire/ — Magyar Bank has announced that Jon R. Ansari, Pennington, NJ has been named Executive Vice President, Chief Financial Officer.

Mr. Ansari has been with Magyar Bank for thirteen years and most recently was Senior Vice President, Chief Financial Officer.  Mr. Ansari is a graduate of Muhlenberg College where he obtained his Bachelor of Arts degree, and received his MBA from New York University.  He is also a graduate of the America’s Community Bankers National School of Banking.

Magyar Bank is a subsidiary of Magyar Bancorp (NASDAQ: MGYR), and is a $520 million asset community bank headquartered in New Brunswick, New Jersey.  Magyar Bank has been serving families and businesses in Central New Jersey since 1922 with a complete line of financial products and services, and today Magyar operates branch locations in Branchburg, Bridgewater, Edison, New Brunswick, North Brunswick and South Brunswick. Visit Magyar online at www.magbank.com.

SOURCE Magyar Bank

3M to Acquire the Business of Federal Signal (FSS)

3M announced today that it has entered into an agreement to acquire the business of Federal Signal Technologies Group (FSTech) from Federal Signal Corp., for a purchase price of $110 million in cash, subject to post-closing adjustments. FSTech focuses on electronic toll collection and parking management hardware and software services.

The fast-growing $3 billion electronic tolling industry is projected to grow at a rate greater than 12 percent per year as government agencies increasingly rely on tolling to fund roadway infrastructure, construction and maintenance. FSTech’s solutions for electronic tolling, vehicle identification and classification, toll management software, license plate recognition, and parking lot fare collection systems, combined with 3M’s traffic management solutions, will advance the tolling and parking industry enabling seamless fare collection wherever motorists drive.

“Electronic tolling and parking are key adjacencies to 3M’s offering for motor vehicle systems and services,” said John Houle, vice president and general manager, 3M Traffic Safety Systems Division. “FSTech will complement 3M’s offerings for the Department of Transportation, the Department of Motor Vehicles, toll authorities, and law enforcement agencies, and expand on our core traffic products for motor vehicles and roadways, and license plate validation materials.”

For more than 70 years 3M has delivered traffic products, systems and services for transportation safety, traffic management, vehicle registration and commercial transportation markets. FSTech’s technologies come from its five business units: IDRIS – vehicle detection and classification solution; PIPS – fixed and mobile automatic license plate reading hardware and software; Federal APD – parking management and fare collection solutions; Sirit – active and passive RFID transponders and readers; and VESystems – toll account management and violation processing software and services.

“3M’s expertise and innovation in the traffic industry make it a natural choice to continue to build this important business for our customers and for drivers everywhere,” said Dan McGurran, director, 3M Motor Vehicle Systems and Services.

On a GAAP reported basis, 3M estimates the acquisition to be $0.02 dilutive to earnings in the first 12 months following completion of the transaction. Excluding purchase accounting adjustments and anticipated integration expenses, 3M estimates the acquisition to be neutral to earnings over the same period.

FSTech employs approximately 500 people and has primary facilities in Arizona, California, Illinois, Michigan, Missouri, North Carolina, Tennessee, Texas, Hong Kong, Dubai and the U.K. The transaction is expected to be completed in the second half of 2012, subject to customary approvals and closing conditions.

Forward-Looking Statements

This news release contains forward-looking information about 3M’s financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” “target,” “forecast” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic and capital markets conditions and other factors beyond the Company’s control, including natural and other disasters affecting the operations of the Company or its customers and suppliers; (2) the Company’s credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) security breaches and other disruptions to the Company’s information technology infrastructure; and (10) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the company’s Annual Report on Form 10-K for the year ended December 31, 2011 and its subsequent quarterly reports on Form 10-Q (the “Reports”). Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Report). The information contained in this news release is as of the date indicated. The company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.

About Federal Signal

Federal Signal Technologies Group is a division of Federal Signal Corp. (NYSE: FSS). Federal Signal Corp. enhances the safety, security and well-being of communities and workplaces around the world. Founded in 1901, Federal Signal is a leading global designer and manufacturer of products and total solutions that serve municipal, governmental, industrial and transportation customers and markets. Headquartered in Oak Brook, IL, with manufacturing facilities worldwide, the company operates four groups: Safety and Security Systems, Environmental Solutions, Fire Rescue, and Federal Signal Technologies. For more information on Federal Signal, please visit: www.federalsignal.com.

About 3M

3M captures the spark of new ideas and transforms them into thousands of ingenious products. Our culture of creative collaboration inspires a never-ending stream of powerful technologies that make life better. 3M is the innovation company that never stops inventing. With $30 billion in sales, 3M employs 84,000 people worldwide and has operations in more than 65 countries. For more information, visit www.3M.com or follow @3MNews on Twitter.

BioMimetic (BMTI) Results from Augment™ Injectable Bone Graft Clinical Trial

Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital and lead investigator, presented today the results of a Canadian registration study comparing Augment™ Injectable Bone Graft (AIBG) to autograft in foot and ankle fusion surgery. Augment Injectable is an injectable bone graft developed by BioMimetic Therapeutics, Inc. (NASDAQ: BMTI). The presentation took place on Thursday, June 21, 2012, at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting. As presented by Dr. Daniels, the trial met its primary endpoint of non-inferiority of AIBG to autograft as assessed by CT scan at six months.

Dr. Daniels reported that assessment of the primary endpoint revealed that 53/63 (84.1%) of the AIBG-treated patients and 100/154 (64.9%) of the autograft-treated patients were fused as determined by six month CT scans (p<0.001). Patients were followed clinically for 52 weeks, at which time 57/63 (90.5%) of the Augment Injectable patients and 120/154 (77.9%) of autograft patients achieved clinical success (p<0.001).

Additionally, patients treated with AIBG were shown to have equivalent functional outcomes with less pain than patients treated with autograft (as seen in the table below).

No safety concerns were identified, and all Augment Injectable-treated patients were spared the additional risk and morbidity of bone graft harvest.

Dr. Daniels commented on the results of the trial, “Augment Injectable Bone Graft demonstrated at least equivalent, and potentially faster, healing outcomes compared to autograft in this study. I have been impressed with the improved handling and delivery characteristics of Augment Injectable compared to other available bone graft alternatives currently being used. Should Augment Injectable receive Health Canada approval, I believe it will be widely used by surgeons who are interested in sparing patients the additional pain and potential risks associated with traditional autograft bone harvest. Further, given the injectable nature of the material and improved handling characteristics, Augment Injectable may expand the indications for bone grafting.”

The Company expects to file the Device License Application (DLA) for approval of Augment Injectable in Canada this summer.

Study Design

This study was a multi-center, randomized (5:1; AIBG to autograft), controlled trial to examine the safety and efficacy of AIBG as compared to autograft for ankle and hindfoot fusions. As pointed out during Dr. Daniels’ presentation, in addition to the prospectively randomized autograft patients, the study utilized the existing autograft database from a previous pivotal clinical trial utilizing a highly similar study design, and including the same surgeons, among others, to increase the statistical robustness of the data as per the study protocol approved by Health Canada.

The primary endpoint was percentage of subjects fused as assessed by CT scan at 24 weeks (defined as ≥50% osseous bridging) as determined by an independent blinded radiologist. CT scans were performed at nine, 16, 24 and 36 weeks. Secondary endpoints included clinical evaluations, such as clinical success rate (no revision surgery required and improved pain on weight bearing), VAS pain assessment, functional outcome assessment scores (AOFAS Ankle-Hindfoot Scale, Foot Function Index, and SF-12) and radiographs. The historical autograft database was derived from the Augment Bone Graft pivotal trial.

Slides from the presentation will be filed by the Company as an exhibit to a Form 8-K following the AOFAS meeting.

About Augment Injectable

Augment Injectable Bone Graft (AIBG) is being developed as an alternative to autograft in orthopedic surgery. In clinical studies, AIBG has been evaluated as a healing adjunct to fusion in hindfoot and ankle surgeries and distal radius fractures. The product is comprised of recombinant human platelet-derived growth factor and a tri-calcium phosphate and collagen carrier (rhPDGF-BB/β-TCP/collagen). At the point of use, the components are mixed and subsequently applied to the surgical site. The final consistency is a flowable paste, which can be extruded through a narrow gauge needle. AIBG is designed for controlled delivery to open surgical sites, to complement minimally invasive surgery or percutaneous delivery. It should be noted that the U.S. FDA has not approved the protocol used in the study reported here by Dr. Daniels, specifically the combining of the autograft patients from the previous Augment Bone Graft pivotal clinical trial. An additional study is currently ongoing in the U.S. and Canada which employs a 2:1 (AIBG:autograft) randomization schedule. The Company plans to utilize the historical autograft dataset as supporting documentation for future Augment Injectable regulatory filings.

About BioMimetic Therapeutics

BioMimetic Therapeutics (NASDAQ: BMTI) is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedics, sports medicine and spine applications. All Augment^® branded products are based upon recombinant human platelet-derived growth factor (rhPDGF-BB), which is an engineered form of PDGF, one of the body’s principal agents to stimulate and direct healing and regeneration. Through the commercialization of this patented technology, BioMimetic seeks to become the leading company in the field of regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments.

BioMimetic has received regulatory approvals to market Augment^® Bone Graft in Canada, Australia and New Zealand for use in hindfoot and ankle fusion indications. Augment is pending regulatory decisions in the U.S. and European Union for similar indications. The Company also markets a bone graft substitute line of products for orthopedic indications called Augmatrix™ Biocomposite Bone Graft.

For further information, contact Kearstin Patterson, senior director of corporate communications, at 615-236-4419.

Forward-looking Statements

This press release contains forward-looking statements about our future results of operations and financial position, product development programs, business strategy, budgets, projected costs, plans and objectives of management for future operations that are not historical facts. The words “may,” “continue,” “estimate,” “intend,” “plan,” “will,” “believe,” “project,” “expect,” “anticipate,” “optimistic” and similar expressions may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. There are many important factors that could cause BioMimetic’s actual results and the timing and outcome of events to differ materially from those expressed or implied in the forward-looking statements because of risks detailed in BioMimetic’s recent annual and quarterly reports filed with the Securities and Exchange Commission, including those factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on March 13, 2012, which are incorporated in this press release by this reference. Except as required by law, BioMimetic undertakes no responsibility for updating the information contained in this press release beyond the published date, whether as a result of new information, future events or otherwise, and has no policy of doing so.

Arizona Private School Association Names Collins College (CECO) 2012 School of the Year

Collins College recently received several significant awards from the Arizona Private School Association (APSA) at its annual conference, including 2012 School of the Year. APSA also honored Collins College with awards for Best Student Services and Best Placement practices.

“Collins College is a great school with a good mission—they give a lot back to their community,” said Fred Lockhart, Executive Director of the APSA. Lockhart also noted that Collins College “excelled” in three out of the 11 award categories.

Collins College has been named APSA School of the Year twice before, in 2005 and 2008. The additional distinctions of the Best Placement Practice and Best Student Service Practice emphasize the outstanding efforts of the Student Services and Career Services departments at Collins College.

“I consider myself very fortunate and feel proud to be a part of the Collins College team. Each day our faculty and staff come in and give their best to our students, and it shows time and time again,” said Christine Murphy, president of Collins College.

APSA has more than 56 member schools across Arizona, making the award of 2012 School of the Year a significant distinction for Collins College. The School of the Year award goes to a college that demonstrates an exceptional commitment to its students across all awards categories.

The recent integration of an Interdisciplinary Project into the curriculum helped distinguish Collins as a worthy candidate for School of the Year. Through the new Interdisciplinary Project, students from diverse degree programs collaborate on a project to help a local agency, usually a non-profit organization. After gaining hands-on professional experience by completing the project, the students then have the opportunity to display their work to employers and other community members through the Student Professional Portfolio Show program. Examples include new brand identity and logo design projects for government agencies and charities.

Student Services’ revamped efforts to improve student retention, satisfaction, and career preparedness were recognized by the Best Student Service Practice award. Collins College achieved its Student Services goals by focusing on four major areas: Student Engagement, Student Recognition, Student Activities, and Professional Development. Some strategies addressing these areas were Student Appreciation Days, the “artWALK” student gallery, skills workshops, and a carpool program.

Collins College’s additional career preparation initiatives were acknowledged by the APSA Best Placement Practice award. This honor highlights the Career Services department’s efforts to prepare students for the future using social media communication, mandating career-focused class presentations and coordinating with community partners to keep students informed and engaged. Besides helping students learn outside the classroom, Career Services has also brought professional training into classrooms by giving presentations on topics including resume development, job search strategies, networking, and portfolio development.

Learn more about the career assistance offered at Collins College by visiting its Career Services web page. If you’re interested in working toward a design and technology degree, Collins College is ready to help you explore your educational options and the professional possibilities you could pursue. Prospective students and employers can contact us for more information.

About Collins College

Collins College, with two locations in Phoenix and Tempe, Ariz., provides students with a career-focused education in the design and technology fields. Collins offers degrees in Audio Production, Game Production, Graphic Design, Fashion Design and Merchandising, Film and Video Production, Web Design and Development, Retail Merchandise Management, Digital Video Production, Internet Marketing and Information Technology. The school is accredited by the Accrediting Council for Independent Colleges and Schools (ACICS). ACICS is a national accrediting agency recognized by the United States Department of Education. Collins College cannot guarantee employment or salary and is part of the Career Education Corporation network of schools (NASDAQ: CECO). Find disclosures on graduation rates, student financial obligations and more at www.collinscollege.edu/disclosures. For more information, visit www.collinscollege.edu.

Hercules Offshore (HERO) and Seadrill Continue to Battle Sliding Oil Prices

NEW YORK, NY — (Marketwire) — 06/20/12 — Oil stocks have struggled over the last month amongst concerns of a potential recession in Europe. The SPDR S&P Oil & Gas Equipment & Services ETF (XES) has fallen over 22 percent in the last three months. As Europe accounts for approximately 20 percent of the world’s consumption of oil, a weak economy would weigh heavily on oil demand. Five Star Equities examines the outlook for companies in the Oil & Gas Drilling & Exploration Industry and provides equity research on Hercules Offshore, Inc. (NASDAQ: HERO) and Seadrill Ltd. (NYSE: SDRL).

Access to the full company reports can be found at:

www.FiveStarEquities.com/HERO

www.FiveStarEquities.com/SDRL

Oil prices Monday fell close to $83 a barrel as results of the recent Greek elections failed to ease concerns of Europe’s growing debt crisis. “Given that the (Greek) government will likely push for an easing of austerity measures… the outlook for Greece remains far from certain, particularly as the debt crisis is spilling over into Spain and potentially Italy,” said analysts at JBC Energy in Vienna.

The Energy Department’s Energy Information Administration in its weekly report showed that U.S. crude supplies dropped by 200,000 barrels. According to Platts analysts had predicted a drop of 2 million barrels for the week ended June 8.

Five Star Equities releases regular market updates on companies in the Oil & Gas Drilling & Exploration Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports and industry newsletters.

Hercules Offshore is a leading provider of offshore contract drilling, liftboat and inland barge services with operations spanning the globe. According to a recent Forbes article Hercules Offshore Inc.’s Director Thomas R. Bates Jr. purchased 40,000 shares at an average cost of $3.42 per share. Shares of the company on Monday fell 9 percent to close at $3.14.

Seadrill is a leading offshore deep-water drilling company. The company is currently in advanced discussions regarding a new five-year contract for the drillship West Polaris. The potential contract revenue for the five-year period is approximately US$1.16 billion. A final agreement is expected within July 2012.

Five Star Equities provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. Five Star Equities has not been compensated by any of the above-mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at:

www.FiveStarEquities.com/disclaimer

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Five Star Equities

Goldwind Selects Broadwind (BWEN) to Supply Towers for Montana Musselshell Project

China’s leading wind energy company, Goldwind, has selected Broadwind Energy (NASDAQ: BWEN) to supply 14 wind turbine towers for its Musselshell project in Shawmut, Montana, set for installation during the second half of 2012.

“We have worked with Broadwind on some of our most visible projects in the Americas including the 109.5 MW Shady Oaks wind farm,” said Tim Rosenzweig, chief executive officer of Goldwind USA. “Broadwind has been an integral part of our efforts to build a domestic supply chain that would ensure the delivery of high-quality projects for our customers and we are pleased to work with its team once again.”

Proven experience, flexibility and quality

With more than 1,200 towers produced to date, Broadwind is a leading U.S. producer of multi-megawatt wind turbine towers. The first in the U.S. to manufacture 100-meter towers, Broadwind applies existing talent to a new American challenge, tapping deep roots in steel fabrication to create the tall steel towers that enable turbines to capture maximum wind energy.

“We are delighted to extend our relationship with Goldwind through another project,” said Peter C. Duprey, president and chief executive officer of Broadwind Energy. “We look forward to future opportunities to support Goldwind’s growth as we work together building quality wind towers and creating local jobs to support America’s need for cleaner energy solutions.”

About Broadwind Energy, Inc.

Broadwind Energy (NASDAQ: BWEN) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears and gearing systems for wind, oil and gas and mining applications to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and weldments, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy’s talented team of 800 employees is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com.

Forward-Looking Statements

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995—that is, statements related to future, not past, events. Forward-looking statements are based on current expectations and include any statement that does not directly relate to a current or historical fact. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “intend,” “expect,” “plan,” “will” or other similar words. These forward-looking statements involve certain risks and uncertainties that ultimately may not prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. The Company’s forward looking statements may include or relate to the Company’s plans to grow its business and its expectations regarding its operations, revenue growth, profitability and the business of its customers; the Company’s expectations regarding its plan to restructure its operations by consolidating its operations; the sufficiency of the Company’s working capital; the Company’s expectations regarding the state of the wind energy market, and the regulatory frameworks affecting the wind energy industry, as well as the Company’s expectations relating to the economic downturn and the potential impact on its business and the business of its customers. For further discussion of risks and uncertainties, individuals should refer to the Company’s SEC filings. The Company undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this news release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. All forward-looking statements are qualified in their entirety by this cautionary statement.

Eagle Bulk Shipping (EGLE) Reaches Comprehensive Agreement With Lenders

Sets Maturity to December 31, 2015 With Company Option to Extend Into 2017

No Fixed Repayment of Principal Until Maturity Date

NEW YORK, June 20, 2012 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (Nasdaq:EGLE) (the “Company”) today announced that it has reached an agreement with a syndicate of its lenders led by Royal Bank of Scotland plc. This agreement resolves all outstanding issues with the Company’s lenders and significantly improves the Company’s position amid the ongoing, cyclical downturn in the shipping markets.

Highlights of the agreement include the following:

• Permanently waives any purported defaults or events of defaults.
• $1,129,478,742 presently outstanding under the existing revolver will convert into a term loan, with a maturity set to December 31, 2015. Subject to certain conditions, the amendment provides an option to the Company to extend the maturity date an additional 18 months to June 30, 2017.
• Eagle Bulk will receive a new liquidity facility in the aggregate amount of $20,000,000.
• The amendment requires no fixed repayments of principal until maturity, and is subject to a quarterly sweep of cash in excess of $20,000,000.
• All amounts presently outstanding under the existing credit agreement will bear interest at LIBOR plus a cash margin of 3.50% and a payment-in-kind (“PIK”) margin of 2.50%.  This aggregate margin can be reduced if Company leverage is lowered.
• Replaces all existing financial covenants and substitutes them with new covenants that phase-in over the next three years.
• Permits within certain parameters for the purchase or sale of vessels and management of third party vessels.

Sophocles N. Zoullas, Eagle Bulk’s Chairman and Chief Executive Officer, commented, “We are pleased to have reached this comprehensive agreement with our syndicate, with whom we have worked constructively and cooperatively.  Eagle Bulk is confident that the agreement materially improves the Company’s current business prospects, and enhances our competitiveness as the market stabilizes,” Mr. Zoullas concluded.

Other pertinent terms of the agreement include:

• All capitalized interest will be evidenced by PIK loans, which will mature on the extended maturity date of either December 31, 2015, or June 30, 2017.  Upon maturity, Eagle Bulk retains several options to repay the PIK loans, including cash repayment or conversion of outstanding amount to Cumulative Convertible Preferred Stock.
• Provides that any Cumulative Convertible Preferred Stock issuable upon conversion of the PIK Loans will bear interest at a coupon rate equal to the lower of (i) the trailing twelve month dividend yield of the S&P US Preferred Stock Index as of the last business day of the month immediately preceding the date of issuance or (ii) the interest rate on the senior debt incurred in any refinancing of the term loan component plus 200bps, and will include customary default in payment of dividend provisions.
• Provides that any Cumulative Convertible Preferred Stock issuable upon conversion of the PIK Loans will have a maturity of five years but may be converted into shares of the Company’s Common Stock at the option of the Company.
• The issuance of warrants to the lenders which are convertible into shares of common stock equal to 19.99% of the Company’s outstanding common stock on June 20, 2012, with a strike price of $0.01 per share. One-third of the warrants are exercisable immediately, one third when the Company’s stock price reaches $10.00 per share and one third when the Company’s stock price reaches $12.00 per share. Unexercised warrants expire on June 20, 2022.

Additional detail about the amendment can be found in the Company’s 8-K Disclosure Statement, a copy of which will be filed with the Securities and Exchange Commission on June 20, 2012, and is available at www.sec.gov.

About Eagle Bulk Shipping Inc.

Eagle Bulk Shipping Inc. is a Marshall Islands corporation headquartered in New York. The Company is a leading global owner of Supramax dry bulk vessels that range in size from 50,000 to 60,000 deadweight tons and transport a broad range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes.

Forward-Looking Statements

Matters discussed in this release may constitute forward-looking statements. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although Eagle Bulk Shipping Inc. believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, Eagle Bulk Shipping Inc. cannot assure you that it will achieve or accomplish these expectations, beliefs or projections.

Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including changes in charter hire rates and vessel values, changes in demand that may affect attitudes of time charterers to scheduled and unscheduled drydocking, changes in our vessel operating expenses, including dry-docking and insurance costs, or actions taken by regulatory authorities, potential liability from future litigation, domestic and international political conditions, potential disruption of shipping routes due to accidents and political events or acts by terrorists.

Risks and uncertainties are further described in reports filed by Eagle Bulk Shipping Inc. with the US Securities and Exchange Commission.

Visit our website at www.eagleships.com

CONTACT: Company Contact:
         Alan Ginsberg
         Chief Financial Officer
         Eagle Bulk Shipping Inc.
         Tel. +1 212-785-2500

         Investor Relations / Media:
         Jonathan Morgan
         Perry Street Communications, New York
         Tel. +1 212-741-0014

China Shen Zhou Mining (SHZ) Provides Update on SRK Technical Assessment Report

BioSante (BPAX) Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it has received notice from The NASDAQ Stock Market indicating that BioSante has regained compliance with the minimum bid price requirement for continued inclusion of its common stock on The NASDAQ Global Market.

As previously announced by BioSante on June 11, 2012 the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy data, consultation with key opinion leaders (KOLs) in female sexual dysfunction, testosterone therapy and placebo effects, as well as a meeting with the U.S. Food and Drug Administration (FDA). BioSante also intends to continue the on-going LibiGel Phase III cardiovascular and breast cancer safety study as per protocol. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women.

About BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante´s products include LibiGel^® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development. BioSante also is developing a portfolio of cancer vaccines, with 17 Phase I and Phase II clinical trials currently on-going. Four of these vaccines have been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA). BioSante´s other products include an FDA-approved testosterone gel for male hypogonadism, which is licensed to Teva Pharmaceuticals USA, Inc., and the Pill-Plus™, an oral contraceptive in Phase II clinical development by Pantarhei Bioscience B.V. BioSante´s first FDA-approved product, Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, is marketed in the U.S. by Jazz Pharmaceuticals, BioSante´s licensee. Additional information is available online at: www.biosantepharma.com.

Forward-Looking Statements

To the extent any statements made in this release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the continued listing of BioSante’s common stock on The NASDAQ Global Market and other statements identified by words such as “plans,” “intends,” “may,” “could,” other words of similar meaning, derivations of such words and the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante´s actual results to be materially different than those expressed in or implied by BioSante´s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, risks and uncertainties related to the market price of BioSante’s securities and its continued listing on The NASDAQ Global Market, uncertainties regarding clinical testing, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing and other success of BioSante´s licensees or sublicensees and BioSante´s future revenues, if any, from its licensees and sublicensees; uncertainties relating to the future and costs of BioSante´s product development programs and BioSante´s need for and ability to obtain additional financing if needed. More detailed information on these and additional factors that could affect BioSante´s actual results are described in BioSante´s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this release speak only as of the date of this release and are based on BioSante´s current beliefs and expectations. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Ascent Solar (ASTI) Accepts Order for EnerPlex TM Charger for Apple’s iPhone

Product debut in Asia in early August

Ascent Solar Technologies, Inc. (NASDAQ:ASTI), a developer of state-of-the-art, flexible thin-film photovoltaic modules, announced today that it has received a purchase order for 50,000 units of its EnerPlex solar charger for the Apple ® (NASDAQ:AAPL) iPhone ® *. The EnerPlex charger was launched in early June, and it was displayed at Ascent’s annual shareholder’s meeting. It was first publicly displayed to the industry at Intersolar in Europe last week. The product takes advantage of Ascent’s ultra-light, thin and flexible solar panels and enables iPhone users to provide supplementary charging of their iPhones with sunlight.

The order is from Ascent’s exclusive distributor in Asia, TFG Radiant, which has advance orders from its channel partners for retail distribution throughout the Asia region. Ascent plans to fulfill the channel orders, supporting the early August retail launch of EnerPlex chargers in Asia.

Ascent Solar’s President and CEO, Victor Lee, said “Initial response to the EnerPlex solar charger has been excellent. We are very encouraged by the initial orders we have received from our distribution partners in Asia and we are receiving strong interest from potential distributors worldwide. We plan to work closely with our channel partners in Asia to support the retail launch of EnerPlex while continuing to pursue expansion opportunities for this revolutionary line of products around the world.”

Lee continued, “Ascent unveiled the EnerPlex charger at Intersolar Europe last week to a tremendous response. The market is clearly excited about our sleek design which provides consumers with a new and fashionable way to power their smartphone. With this launch of our first EnerPlex product, with many more to come, we are taking the first step toward driving a new revenue stream with significant growth opportunity for the company.”

This charger is the first product under Ascent’s new EnerPlex line of consumer products. Ascent is developing future products for other leading smart phones and consumer devices, such as the Samsung ® Galaxy S ® III *.

Photos, a promotional video, and product information can be found at www.ascentsolar.com/enerplex.

About Ascent Solar Technologies:

Ascent Solar Technologies, Inc. is a developer of thin-film photovoltaic modules using flexible substrate materials that can transform the way solar power generation integrates into everyday life. Ascent Solar modules can be directly integrated into standard building materials, commercial transportation, automotive solutions, space applications, consumer electronics for portable power and durable off-grid solutions. Additional information can be found at www.ascentsolar.com.

* Apple and iPhone are registered trademarks of Apple Inc.

Samsung and Galaxy S are registered trademarks of Samsung Electronics Co., Ltd.

Samsung Galaxy is a trademark of Samsung Electronics Co., Ltd.

Forward-Looking Statements

Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company’s actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “believes,” “belief,” “expects,” “expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans,” “plan,” to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the SEC.